Champions Oncology, Inc. (CSBR)
4.93
+0.07
(+1.44%)
USD |
NASDAQ |
Oct 27, 09:33
Champions Oncology Enterprise Value : 74.82M for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 74.82M |
| October 23, 2026 | 72.87M |
| October 22, 2026 | 73.43M |
| October 21, 2026 | 74.68M |
| October 20, 2026 | 74.13M |
| October 19, 2026 | 72.46M |
| October 16, 2026 | 72.60M |
| October 15, 2026 | 73.85M |
| October 14, 2026 | 74.13M |
| October 13, 2026 | 75.38M |
| October 12, 2026 | 76.12M |
| October 09, 2026 | 74.54M |
| October 08, 2026 | 76.49M |
| October 07, 2026 | 75.10M |
| October 06, 2026 | 76.91M |
| October 05, 2026 | 76.35M |
| October 02, 2026 | 75.94M |
| October 01, 2026 | 75.10M |
| September 30, 2026 | 76.77M |
| September 29, 2026 | 73.85M |
| September 28, 2026 | 75.80M |
| September 25, 2026 | 75.38M |
| September 24, 2026 | 76.08M |
| September 23, 2026 | 77.05M |
| September 22, 2026 | 80.81M |
| Date | Value |
|---|---|
| September 21, 2026 | 80.39M |
| September 18, 2026 | 80.95M |
| September 17, 2026 | 77.89M |
| September 16, 2026 | 76.08M |
| September 15, 2026 | 73.57M |
| September 14, 2026 | 75.66M |
| September 11, 2026 | 78.16M |
| September 10, 2026 | 78.10M |
| September 09, 2026 | 76.91M |
| September 08, 2026 | 77.47M |
| September 04, 2026 | 79.83M |
| September 03, 2026 | 80.67M |
| September 02, 2026 | 78.86M |
| September 01, 2026 | 76.77M |
| August 31, 2026 | 76.70M |
| August 28, 2026 | 75.80M |
| August 27, 2026 | 77.05M |
| August 26, 2026 | 75.66M |
| August 25, 2026 | 76.49M |
| August 24, 2026 | 76.35M |
| August 21, 2026 | 76.22M |
| August 20, 2026 | 79.28M |
| August 19, 2026 | 75.94M |
| August 18, 2026 | 78.02M |
| August 17, 2026 | 77.19M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medpace Holdings, Inc. | 18.35B |
| Avantor, Inc. | 15.09B |
| Personalis, Inc. | 1.514B |
| Adaptive Biotechnologies Corp. | 4.252B |
| 10X Genomics, Inc. | 9.032B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.426M |
| Revenue (Quarterly) | 15.23M |
| Total Expenses (Quarterly) | 15.66M |
| EPS Diluted (Quarterly) | -0.0306 |
| Gross Profit Margin (Quarterly) | 48.48% |
| Profit Margin (Quarterly) | -2.80% |
| Earnings Yield | -1.63% |
| Normalized Earnings Yield | -1.627 |